MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
Funding: U.S. Federal
*Funding: HHS
*HHS: Contracts, Contractors & Awards
*BARDA: Contracts (IDIQ, GWACS, Etc.), Contractors & Awardees
*Contractors & Awardees: BARDA
Biota Pharmaceuticals (NASDAQ:BOTA)
Finance & Acquisition: Biota
Parents
Biota Pharmaceuticals (NASDAQ:BOTA)
Children
2014: Biota Pharmaceuticals Inc Prices $25 Million Public Offering (2014)
2015: The company additionally has royalty streams from Relenza and Inavir that help to lessen cash burn.
2015: With Phase 2 readouts from three exciting programs in 2016 and $66.3 million in cash/equivalents at Q3 end, Biota presents a unique value proposition to investors.
Anaconda Pharmaceutical
Jumps
*Key People: Biota
Organization & Developments: Biota